1. Home
  2. STVN vs HQY Comparison

STVN vs HQY Comparison

Compare STVN & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • HQY
  • Stock Information
  • Founded
  • STVN 1949
  • HQY 2002
  • Country
  • STVN Italy
  • HQY United States
  • Employees
  • STVN N/A
  • HQY N/A
  • Industry
  • STVN Containers/Packaging
  • HQY Business Services
  • Sector
  • STVN Consumer Discretionary
  • HQY Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • HQY Nasdaq
  • Market Cap
  • STVN 7.4B
  • HQY 8.1B
  • IPO Year
  • STVN 2021
  • HQY 2014
  • Fundamental
  • Price
  • STVN $23.81
  • HQY $93.33
  • Analyst Decision
  • STVN Buy
  • HQY Strong Buy
  • Analyst Count
  • STVN 4
  • HQY 15
  • Target Price
  • STVN $25.13
  • HQY $119.93
  • AVG Volume (30 Days)
  • STVN 236.3K
  • HQY 746.2K
  • Earning Date
  • STVN 11-06-2025
  • HQY 12-08-2025
  • Dividend Yield
  • STVN 0.25%
  • HQY N/A
  • EPS Growth
  • STVN 19.59
  • HQY 37.24
  • EPS
  • STVN 0.60
  • HQY 1.65
  • Revenue
  • STVN $1,373,267,629.00
  • HQY $1,268,928,000.00
  • Revenue This Year
  • STVN $8.33
  • HQY $10.27
  • Revenue Next Year
  • STVN $10.12
  • HQY $8.24
  • P/E Ratio
  • STVN $40.84
  • HQY $56.30
  • Revenue Growth
  • STVN 6.98
  • HQY 15.45
  • 52 Week Low
  • STVN $17.49
  • HQY $74.07
  • 52 Week High
  • STVN $28.00
  • HQY $116.65
  • Technical
  • Relative Strength Index (RSI)
  • STVN 40.97
  • HQY 48.22
  • Support Level
  • STVN $23.09
  • HQY $91.24
  • Resistance Level
  • STVN $27.00
  • HQY $95.12
  • Average True Range (ATR)
  • STVN 1.33
  • HQY 2.39
  • MACD
  • STVN -0.18
  • HQY -0.22
  • Stochastic Oscillator
  • STVN 14.69
  • HQY 30.02

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Share on Social Networks: